Skip to main content
Caplight Logo









GemmaCert

GemmaCert

Private
IsraelHealthcare & Life Scienceshttps://gemmacert.com/

Last Round

Series B

Aug 13, 2019

Est. Valuation

$28.6M

Total Funding Raised

$6.75M

Company Overview

GemmaCert is a life sciences company that provides a non-destructive desktop cannabis composition and potency testing solution.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Sensors, Quality Management

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

potency testingcannabis testingnon-destructive testinghemp testingin-house testingNIR spectroscopycannatechNear-Infrared Spectroscopycannabis quality controlanalytical deviceTHC testingCBD testingmachine learninghardware subscriptionagtechchemometrics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GemmaCert Comparables

Compare GemmaCert with similar companies based on industry and business-model similarity.

GemmaCert comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Purpl Scientific
84%
Orange Photonics
80%
Big Sur Scientific
78%

GemmaCert Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BAug 13, 2019
Series A ExtensionFeb 13, 2018
SeedJan 31, 2017

GemmaCert Investors

Notable investors and investment history

GemmaCert investors
InvestorRounds
Neo VenturesSeries A Extension
The Hebrew University of JerusalemSeries B
Yissum Research Development Company of the Hebrew University of JerusalemSeries A Extension, Seed
Arba Finance CompanySeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 13, 2019

    Raised $4M with The Hebrew University of Jerusalem

  • Feb 13, 2018

    Raised $2.25M led by Neo Ventures and Applied BioSciences Corp.

GemmaCert Filings

Explore SEC and related filing metadata, where available.

GemmaCert filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about GemmaCert's valuation, stock price, and market status.

Is GemmaCert a public or private company?

GemmaCert is a private company.

What is the current stock price of GemmaCert?

GemmaCert is a private company with no public stock price. No recent secondary market data is available.

How much is GemmaCert worth (valuation)?

GemmaCert's valuation is estimated at $28.6M based on funding round data.

Can I buy GemmaCert stock?

GemmaCert shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was GemmaCert's last funding round?

GemmaCert's most recent funding round was Series B on August 13, 2019.

Who are the main investors in GemmaCert?

Key investors in GemmaCert include Neo Ventures, Arba Finance Company.

Will GemmaCert IPO soon?

No public IPO plans have been announced for GemmaCert.

How can I track GemmaCert secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GemmaCert's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIsrael
Employee Range7
Year Founded2015
Last FundingAug 13, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?